within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B01A_AntithromboticAgents.B01AD06_Brinase;
model Brinase 
   extends Pharmacolibrary.Drugs.ATC.B.B01AD06;

  annotation(Documentation(
    info ="<html><body><p>Brinase (streptokinase from Streptomyces griseus) is a fibrinolytic enzyme formerly used as a thrombolytic agent for the treatment of acute myocardial infarction and other thromboembolic events. Brinase is a proteolytic enzyme but is no longer widely used today due to safety and efficacy concerns, and the drug is not presently approved for clinical use.</p><h4>Pharmacokinetics</h4><p>No published sources report detailed pharmacokinetic parameters for brinase in humans. The following are plausible estimates based on typical intravenous enzyme thrombolytics.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Brinase;
